continuous glucose monitor
Data from Dexcom CGMs will be integrated into FriskaAi and will be monitored by AI-powered algorithms that alert patients when action is advised.
The announcement comes less than a year after Dexcom announced a strategic partnership and $75 million investment in the health-tracking ring maker.
The G7 continuous glucose monitoring system will have a 15.5-day wear time and last 15% longer than Dexcom G7, according to the company.
Jake Leach, executive VP and chief operating officer at Dexcom, joined MobiHealthNews to discuss the company's evolution and offerings beyond diabetes.
The continuous glucose monitoring system can be used to measure glucose levels in adults with diabetes for up to six months.
Dexcom’s Partner Web APIs will allow users to view all of their diabetes care data in one place to enable in-the-moment feedback and adjustments.
More than 11 million Canadians live with diabetes or prediabetes, making up 29% of the country’s population.
Movano's smartwatch-like wearable uses radio frequency technology to measure blood glucose without breaking the skin.
Members in 27 states and Washington D.C. are eligible to receive the Level2 chronic care model at no additional cost.
From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes.